Chia Tai Enterprises International Ltd (HKSE:03839) Share Price

Company Profile

Business description
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segments include Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
Contact
16 Harcourt Road
21st Floor, Far East Finance Centre
Hong Kong
HKG
T: +852 25201601
http://www.ctei.com.hk
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
900

Recommended

This share is trading at the lowest price to fair value of the 14 companies on the list.

Angus Hewitt, CFA | 05 January 2026

Despite a surging share price a weakening competitive position causes a reassessment of our view.

Shane Ponraj, CFA | 05 January 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.

Margaret Giles | 04 January 2026

Index	Last price	Change	% Change
All Ordinaries	8,996.90	37.80	-0.42%
CAC 40	8,247.33	35.83	0.44%
DAX 40	24,896.94	28.25	0.11%
Dow JONES (US)	49,198.70	221.52	0.45%
FTSE 100	10,132.02	127.45	1.27%
HKSE	26,710.45	363.21	1.38%
NASDAQ	23,435.53	39.70	0.17%
Nikkei 225	52,518.08	685.28	1.32%
NZX 50 Index	13,663.58	76.35	0.56%
S&P 500	6,918.15	16.10	0.23%
S&P/ASX 200	8,682.80	45.80	-0.52%
SSE Composite Index	4,083.67	60.25	1.50%